Alkermes plc. Income Taxes Paid
Alkermes plc. (ALKS) reported Income Taxes Paid of $13.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-07-28
- Alkermes plc. income taxes paid, net for the quarter ending 2026-06-30 was $12.08M, a 965.84% increase year-over-year.
- Alkermes plc. income taxes paid, net for the quarter ending 2026-03-31 was $1.85M, a 303.93% increase year-over-year.
- Alkermes plc. income taxes paid, net for the quarter ending 2025-12-31 was $2.13M, a 221.60% increase year-over-year.
- Alkermes plc. income taxes paid, net for the quarter ending 2025-09-30 was $1.52M.
- Alkermes plc. income taxes paid, net for fiscal 2025 was $5.24M, a 102.04% increase from fiscal 2024.
- Alkermes plc. income taxes paid, net for fiscal 2024 was $2.59M, a 94.14% decline from fiscal 2023.
- Alkermes plc. income taxes paid, net for fiscal 2023 was $44.24M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $13.93M 10-Q · filed 2026-07-28 | $16.05M derived: sum of 3 quarters · filed 2026-07-28 | $17.57M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $1.85M 10-Q · filed 2026-05-05 | $3.98M derived: sum of 2 quarters · filed 2026-05-05 | $5.50M derived: sum of 3 quarters · filed 2026-05-05 | $6.63M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.65M derived: sum of 2 quarters · filed 2026-02-25 | $4.78M derived: sum of 3 quarters · filed 2026-07-28 | $5.24M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.65M derived: sum of 2 quarters · filed 2026-07-28 | $3.11M 10-Q · filed 2025-10-28 | $3.77M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $1.59M 10-Q · filed 2026-07-28 | $2.25M derived: sum of 3 quarters · filed 2026-07-28 | |
| 2025-03-31 | $458.00K 10-Q · filed 2026-05-05 | $1.12M derived: sum of 2 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.59M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $1.93M 10-Q · filed 2025-10-28 | |||
| 2023-12-31 | $44.24M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |